Second primary malignancies in treated and untreated patients with chronic lymphocytic leukemia

Am J Hematol. 2021 Dec 1;96(12):E457-E460. doi: 10.1002/ajh.26363. Epub 2021 Oct 8.

Moritz Fürstenau^{1

2}, Adam Giza¹, Thomas Stumpf¹, Sandra Robrecht¹, Christian Maurer^{1

2}, Hartmut Linde³, Lutz Jacobasch⁴, Steffen Dörfel⁵, Ali Aldaoud⁶, Julia von Tresckow⁷, Michael Koenigsmann⁸, Tobias Gaska⁹, Ulrich Kaiser¹⁰, Hanns-Detlev Harich¹¹, Kirsten Fischer¹, Barbara Eichhorst^{1

2}, Michael Hallek^{1

2

12}, Anna-Maria Fink¹

¹ Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany.
² Cancer Center Cologne Essen (CCCE)-Partner Site Cologne, University of Cologne, Cologne, Germany.
³ MVZ für Blut- und Krebserkrankungen Potsdam, Potsdam, Germany.
⁴ BAG Freiberg-Richter, Jacobasch, Wolf, Illmer, Dresden, Germany.
⁵ Onkologische Gemeinschaftspraxis Dres. Dörfel/Göhler/Boldt, Dresden, Germany.
⁶ Praxis für Hämatologie/ Onkologie Dr. Aldaoud, Leipzig, Germany.
⁷ Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
⁸ Onkologisches Ambulanzzentrum, Hannover, Germany.
⁹ Brüderkrankenhaus, Paderborn, Germany.
¹⁰ VK&K Studien GbR, Landshut, Landshut, Germany.
¹¹ Onkologie Hof MVZ GmbH, Hof, Germany.
¹² Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

No abstract available

Publication types